Literature DB >> 20456505

A screening algorithm for HIV-associated neurocognitive disorders.

L A Cysique1, J M Murray, M Dunbar, V Jeyakumar, B J Brew.   

Abstract

BACKGROUND: HIV physicians have limited time for cognitive screening. Here we developed an extra-brief, clinically based tool for predicting HIV-associated neurocognitive impairment (HAND) in order to determine which HIV-positive individuals require a more comprehensive neurological/neuropsychological (NP) assessment.
METHODS: Ninety-seven HIV-positive individuals with advanced disease recruited in an HIV out-patient clinic received standard NP testing. A screening algorithm was developed using support vector machines, an optimized prediction procedure for classifying individuals into two groups (here NP-impaired and NP-normal) based on a set of predictors.
RESULTS: The final algorithm utilized age, current CD4 cell count, past central nervous system HIV-related diseases and current treatment duration and required approximately 3 min to complete, with a good overall prediction accuracy of 78% (against the gold standard; NP-impairment status derived from standard NP testing) and a good specificity of 70%.
CONCLUSION: This noncognitive-based algorithm should prove useful to identify HIV-infected patients with advanced disease at high risk of HAND who require more formal assessment. We propose staged guidelines, using the algorithm, for improved HAND therapeutic management. Future larger, international studies are planned to test the predictive effect of nadir CD4 cell count, hepatitis C virus infection, gender, ethnicity and HIV viral clade. We recommend the use of this first version for HIV-infected Caucasian men with advanced disease.
© 2010 British HIV Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456505     DOI: 10.1111/j.1468-1293.2010.00834.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  21 in total

1.  The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.

Authors:  Sapna M Patel; April D Thames; Natalie Arbid; Stella E Panos; Steven Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2013-04-03       Impact factor: 2.475

2.  A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.

Authors:  Mark Bloch; Jody Kamminga; Avindra Jayewardene; Michael Bailey; Angela Carberry; Trina Vincent; Dick Quan; Paul Maruff; Bruce Brew; Lucette A Cysique
Journal:  Clin Infect Dis       Date:  2016-06-19       Impact factor: 9.079

3.  The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment.

Authors:  María J Marquine; Anya Umlauf; Alexandra S Rooney; Pariya L Fazeli; Ben D Gouaux; Steven Paul Woods; Scott L Letendre; Ronald J Ellis; Igor Grant; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

4.  Factors related to HIV-associated neurocognitive impairment differ with age.

Authors:  Gary B Fogel; Susanna L Lamers; Andrew J Levine; Miguel Valdes-Sueiras; Michael S McGrath; Paul Shapshak; Elyse J Singer
Journal:  J Neurovirol       Date:  2014-11-18       Impact factor: 2.643

5.  A Smartphone App to Screen for HIV-Related Neurocognitive Impairment.

Authors:  Reuben N Robbins; Henry Brown; Andries Ehlers; John A Joska; Kevin G F Thomas; Rhonda Burgess; Desiree Byrd; Susan Morgello
Journal:  J Mob Technol Med       Date:  2014-02-01

Review 6.  Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.

Authors:  Jody Kamminga; Luxshimi Lal; Edwina J Wright; Mark Bloch; Bruce J Brew; Lucette A Cysique
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

Review 7.  Screening for cognitive impairment in human immunodeficiency virus.

Authors:  Victor Valcour; Robert Paul; Stephanie Chiao; Lauren A Wendelken; Bruce Miller
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

8.  Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.

Authors:  Erin E Morgan; Steven Paul Woods; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-02-15       Impact factor: 2.813

Review 9.  Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era.

Authors:  Adriana Carvalhal; Jean-Guy Baril; Frederic Crouzat; Joss De Wet; Patrice Junod; Colin Kovacs; Nancy Sheehan
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

10.  The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.

Authors:  Edward R Hammond; Rosa M Crum; Glenn J Treisman; Shruti H Mehta; Christina M Marra; David B Clifford; Susan Morgello; David M Simpson; Benjamin B Gelman; Ronald J Ellis; Igor Grant; Scott L Letendre; Justin C McArthur
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.